Panbela Therapeutics (PBLA)
OTHER OTC:PBLA
US Market
Holding PBLA?
Track your performance easily

Panbela Therapeutics (PBLA) Financial Statements

242 Followers

Panbela Therapeutics Financial Overview

Panbela Therapeutics's market cap is currently ―. The company's EPS TTM is $-84.774; its P/E ratio is >-0.01; Panbela Therapeutics is scheduled to report earnings on November 14, 2024, and the estimated EPS forecast is $-1.63. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -7.14M$ -7.20M$ -6.42M$ -5.91M$ -5.03M
EBITDA$ -7.14M$ -7.20M$ -6.42M$ -5.91M$ -5.03M
Net Income Common Stockholders$ -7.14M$ -7.12M$ -6.47M$ -5.83M$ 4.61M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 59.00K$ 262.00K$ 2.58M$ 7.21M$ 5.24M
Total Assets$ 9.41M$ 10.53M$ 11.80M$ 19.55M$ 16.48M
Total Debt$ 4.19M$ 4.19M$ 5.19M$ 5.19M$ 5.19M
Net Debt$ 4.13M$ 3.93M$ 2.62M$ -2.01M$ -41.00K
Total Liabilities$ 19.98M$ 13.71M$ 16.51M$ 14.75M$ 13.94M
Stockholders Equity$ -10.57M$ -3.19M$ -4.71M$ 4.80M$ 2.54M
Cash Flow-
Free Cash Flow$ -206.00K$ -9.39M$ -3.08M$ -5.74M$ -9.75M
Operating Cash Flow$ -981.00K$ -9.39M$ -3.08M$ -5.74M$ -9.75M
Investing Cash Flow$ 775.00K----
Financing Cash Flow-$ 7.08M$ 4.75M$ 7.71M$ 13.70M
Currency in USD

Panbela Therapeutics Earnings and Revenue History

Panbela Therapeutics Debt to Assets

Panbela Therapeutics Cash Flow

Panbela Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis